Integrated Diag Hdgs - Director/PDMR Shareholding

Integrated Diagnostics Holdings

Tue 17:05

RNS Number : 4534J
  
Integrated Diagnostics Holdings PLC
  
23 June 2026
  
 



 

 
Integrated Diagnostic Holdings plc
23 June 2026
 
 
INTEGRATED DIAGNOSTIC HOLDINGS PLC
 
 
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
 
The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).
 
 




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Legal Person:
 
Hena Holdings Ltd
 




2


Reason for the notification








a)


Position/status


PCA of Dr Hend El Sherbini, Chief Executive Officer
 




b)


Initial notification/Amendment


Initial Notification




3


Details of the issuer, UK emission allowance market participant, auction platform or auctioneer








a)


Name


Integrated Diagnostics Holdings plc




b)


LEI


2138007JN9NUWKKTS790




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code


IDH Ordinary Share of $0.25 each
 
 
Identification Code: JE00BLKGSR75




b)


Nature of the transaction


Purchase of shares from Actis IDH Limited




c)


Price(s) and volume(s)


Price(s)                                                                                                 Volume(s)












Currency: USD
Price: 0.50
Volume: 126,000,000
Total: 63,000,000




d)


Aggregated information
 


Price: USD 0.50 per share
Volume: 126,000,000
Total: 63,000,000




e)


Date of the transaction


23 June 2026




f)


Place of the transaction


London Stock Exchange




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBLGDLXGDDGLX